CMRA vs. EVLO, GNCAQ, GNCA, ARDS, STAB, AMPE, CALA, EFTR, CLVR, and ONCSQ
Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), Clever Leaves (CLVR), and OncoSec Medical (ONCSQ). These companies are all part of the "pharmaceutical products" industry.
Comera Life Sciences vs.
Evelo Biosciences (NASDAQ:EVLO) and Comera Life Sciences (NASDAQ:CMRA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.
Evelo Biosciences has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Comera Life Sciences has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.
Evelo Biosciences received 170 more outperform votes than Comera Life Sciences when rated by MarketBeat users.
Comera Life Sciences has higher revenue and earnings than Evelo Biosciences.
In the previous week, Evelo Biosciences' average media sentiment score of 0.32 beat Comera Life Sciences' score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the media.
0.3% of Evelo Biosciences shares are held by institutional investors. 1.0% of Evelo Biosciences shares are held by company insiders. Comparatively, 8.9% of Comera Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Evelo Biosciences and Comera Life Sciences tied by winning 3 of the 6 factors compared between the two stocks.
Get Comera Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Comera Life Sciences Competitors List
Related Companies and Tools
This page (NASDAQ:CMRA) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy CMRA Stock Free CMRA Stock Alerts